Business & Industry
Sanofi to Buy Vaccine Developer Dynavax in a $2.5b Deal
The French pharma giant, Sanofi, has started a $15.50 per share cash tender offer when it comes to Emeryville, California-based vaccine developer Dynavax, which already goes on to market an adult vaccine that protects against the hepatitis B virus...
BioPharma
AstraZeneca Commits $100mn for Pan-KRAS Inhibitor by Jacobio
AstraZeneca has gone ahead and committed $100 million to head deeper into the KRAS space by way of securing the right when it comes to a clinical-stage, multitarget asset from Jacobio Pharma of China.
The U.K.-based pharma giant has scored...
BioPharma
Laboratory Equipment Outsourcing Through CDMOs: Strategic and Cost Implications
Outsourcing laboratory infrastructure to CDMOs offers pharma companies critical agility, transforming fixed capital costs into flexible operational expenses while accessing cutting-edge technology like Cryo-EM.
Business & Industry
Samsung Biologics to Buy US Drug Plant from GSK for $280M
On December 22, 2025, the news has been confirmed of Samsung Biologics to Buy US Drug Plant which is going to be its first US drug production facility from GSK plc for $280 million in order to reduce risks...
Business & Industry
Novartis to Lower Innovative Medicines Price in the US
Novartis, which is a leading global innovative medicines company, went ahead and announced on December 19, 2025, that it has reached an agreement along with the US government that aims to lower innovative medicines price in the US and also...
Business & Industry
New Agreements with Pharmaceuticals Target Lower U.S. Drug Prices
President Donald Trump on December 19, 2025, said that his administration has reached agreements with nine additional pharmaceutical companies, therefore extending a campaign that is aimed at decreasing the prescription drug prices for certain Americans while at the same...
Business & Industry
First GLP-1 Pill for Obesity by Novo Nordisk Approved by FDA
The U.S. Food and Drug Administration – FDA on December 22, 2025, gave an approval to the first GLP-1 pill for obesity from Novo Nordisk, the Wegovy maker. This can surely be called a landmark decision, which, as per health...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
